Get Our FREE Newsletter

Sign Up

Here's Why Inhibrx Stock Is on the Move Today

Spread the love

What happened
Shares of Inhibrx (NASDAQ: INBX), a clinical-stage biotechnology company, jumped when the market opened today. Investors excited about the company’s latest clinical trial readout pushed the stock 26.8% higher as of 11:29 a.m. on Tuesday.

This post was originally published on this site